Adocia is a company headquartered in France.
Adocia is a clinical-stage biotechnology company developing innovative formulations of insulins and other metabolic hormones for the treatment of diabetes and obesity.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.